Cargando…

Preclinical Pharmacokinetics and Acute Toxicity in Rats of 5-{[(2E)-3-Bromo-3-carboxyprop-2-enoyl]amino}-2-hydroxybenzoic Acid: A Novel 5-Aminosalicylic Acid Derivative with Potent Anti-Inflammatory Activity

Compound 5-{[(2E)-3-bromo-3-carboxyprop-2-enoyl]amino}-2-hydroxybenzoic acid (C1), a new 5-aminosalicylic acid (5-ASA) derivative, has proven to be an antioxidant in vitro and an anti-inflammatory agent in mice. The in vivo inhibition of myeloperoxidase was comparable to that of indomethacin. The ai...

Descripción completa

Detalles Bibliográficos
Autores principales: Gutiérrez-Sánchez, Mara, Romero-Castro, Aurelio, Correa-Basurto, José, Rosales-Hernández, Martha Cecilia, Padilla-Martínez, Itzia Irene, Mendieta-Wejebe, Jessica Elena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8617944/
https://www.ncbi.nlm.nih.gov/pubmed/34833894
http://dx.doi.org/10.3390/molecules26226801